Coronavirus | Bombay HC refuses to hear PIL seeking uniform rate of COVID-19 vaccines
The Hindu
“In a situation where the entire country is gripped with the COVID-19 pandemic, price control by the govt is a must and such kind of loot and blackmail should not be permitted,” the PIL said
The Bombay High Court on April 29 refused to hear a PIL seeking a direction to the Serum Institute of India and the Bharat Biotech to sell their COVID-19 vaccines at a uniform rate of ₹150 (plus GST) per dose. The public interest litigation (PIL), filed last week by Mumbai-based advocate Fayzan Khan and three law students, had challenged the different rates of COVID-19 vaccines for the Centre and State governments. The plea was mentioned on April 29 by the petitioner’s advocate, Vivek Shukla, before a Division Bench of Chief Justice Dipankar Datta and Justice G.S. Kulkarni, seeking urgent hearing.More Related News